Y-Intercept (HK)
ACAD icon

Y-Intercept (HK)’s Acadia Pharmaceuticals ACAD Stock Holding History

Y-Intercept (HK)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.71M Buy
+382,749
New +$10.3M 0.17% 131
2026
Q2 		– Sell
-25,664
Closed -$571K – 1656
2026
Q1 		$571K Buy
+25,664
New +$613K 0.01% 1229
2025
Q4 		– Sell
-111,273
Closed -$2.37M – 1486
2025
Q3 		$2.37M Buy
+111,273
New +$2.63M 0.06% 512
2025
Q2 		– Sell
-14,527
Closed -$241K – 1593
2025
Q1 		$241K Sell
14,527
-18,378
-56% -$334K 0.02% 983
2024
Q4 		$604K Sell
32,905
-17,639
-35% -$285K 0.04% 638
2024
Q3 		$777K Sell
50,544
-39,245
-44% -$655K 0.05% 554
2024
Q2 		$1.46M Sell
89,789
-51,647
-37% -$834K 0.08% 347
2024
Q1 		$2.62M Buy
+141,436
New +$3.5M 0.2% 115
2023
Q4 		– Sell
-68,887
Closed -$1.44M – 1178
2023
Q3 		$1.44M Buy
68,887
+48,928
+245% +$1.33M 0.14% 216
2023
Q2 		$478K Sell
19,959
-8,190
-29% -$182K 0.05% 578
2023
Q1 		$530K Buy
28,149
+4,286
+18% +$81.6K 0.06% 497
2022
Q4 		$380K Sell
23,863
-5,278
-18% -$82.5K 0.06% 546
2022
Q3 		$477K Buy
29,141
+15,071
+107% +$244K 0.05% 556
2022
Q2 		$198K Buy
14,070
+4,169
+42% +$77.8K 0.03% 686
2022
Q1 		$240K Sell
9,901
-98
-1% -$2.37K 0.05% 538
2021
Q4 		$233K Buy
+9,999
New +$201K 0.06% 470

Other funds holding ACAD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Gradient Investments
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Y-Intercept (HK)'s ACAD Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 382,749 shares worth $7.71M. The stake represents 0.17% of the portfolio and ranks #131 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ACAD as recently as Q1 2026.

Y-Intercept (HK) first reported a position in ACAD in Q4 2021 and has held it in 16 quarters since. 35 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Y-Intercept (HK) held 382,749 shares of Acadia Pharmaceuticals worth $7.71M as of Q3 2026.
  • Acadia Pharmaceuticals was a new Y-Intercept (HK) position in Q3 2026.
  • Acadia Pharmaceuticals made up 0.17% of Y-Intercept (HK)'s portfolio in Q3 2026, its #131 holding.
  • Y-Intercept (HK) first reported a position in Acadia Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • 35 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.